IRIDEX

Yahoo Finance • 3 days ago

Analysts Expect 10% Upside For BKLC

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 23 days ago

Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance

MOUNTAIN VIEW, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of... Full story

Yahoo Finance • last month

Tuesday's Insider Activity: Top Buys and Sells in US Stocks Revealed

This article summarizes the most significant insider buys and sells reported for US stocks on Tuesday, August 19, 2025. Top Insider Buys: Atara Biotherapeutics, Inc. (NASDAQ:ATRA) saw Director James Huang purchase 55,000 shares of common... Full story

Yahoo Finance • last month

Iridex director Moore buys $14k in shares

Director William M. Moore of Iridex Corp (NASDAQ:IRIX), a micro-cap medical technology company valued at $19.63 million, recently purchased 12,024 shares of common stock. The shares were bought at a weighted average price of $1.1834, for a... Full story

Yahoo Finance • last month

Iridex CFO Dizon buys shares worth $1.8k

Iridex Corp (NASDAQ:IRIX) Chief Financial Officer Romeo R. Dizon acquired shares of common stock in two transactions on August 18, 2025, showing insider confidence despite the stock’s 31% decline year-to-date. According to InvestingPro ana... Full story

Yahoo Finance • last month

Iridex CFO Dizon buys $1.7k in IRIX stock

Romeo R. Dizon, Chief Financial Officer of Iridex Corp (NASDAQ:IRIX), recently purchased shares of the company’s common stock. According to a Form 4 filing with the Securities and Exchange Commission, Dizon acquired a total of 1,500 shares... Full story

Yahoo Finance • 2 months ago

Iridex outlines further cost reductions and targets profitability in 2025 as Q2 revenue rises 14% sequentially

Earnings Call Insights: IRIDEX Corporation (IRIX) Q2 2025 MANAGEMENT VIEW * CEO Patrick Mercer highlighted that IRIDEX achieved year-over-year revenue growth, operating expense reductions, and positive adjusted EBITDA for the third con... Full story

Yahoo Finance • 2 months ago

Earnings call transcript: IRIDEX beats Q2 2025 EPS and revenue estimates

IRIDEX Corporation (IRIX) reported its second-quarter earnings for 2025, showcasing a better-than-expected performance with an EPS of -$0.06, surpassing the forecasted -$0.09. The company also exceeded revenue expectations, reporting $13.6... Full story

Yahoo Finance • 2 months ago

Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025

MOUNTAIN VIEW, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of gl... Full story

Yahoo Finance • 3 months ago

Vicarious Surgical adds two new directors to board

WALTHAM, Mass. - Surgical robotics company Vicarious Surgical Inc. (NYSE:RBOT), currently valued at $1.59 billion and showing strong momentum with a 27.61% gain last week, announced Monday the election of Fuad Ahmad and Joseph Doherty to i... Full story

Yahoo Finance • 4 months ago

IRIDEX expands stock plan and amends charter

IRIDEX Corporation (NASDAQ:IRIX), a provider of innovative ophthalmic laser-based medical products currently trading at $0.94 per share, announced the results of its 2025 Annual Meeting of Stockholders held on June 11, 2025. According to I... Full story

Yahoo Finance • 4 months ago

Iridex director William Moore buys $29,121 in stock

In recent transactions, William M. Moore, a director at Iridex Corp (NASDAQ:IRIX), purchased a total of 30,000 shares of common stock over two days. The insider buying comes as the stock trades near $0.96, having declined over 45% in the p... Full story

Yahoo Finance • 6 months ago

Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025

MOUNTAIN VIEW, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of gl... Full story

Yahoo Finance • 6 months ago

Iridex to Host Strategic Vision Call on April 16, 2025

MOUNTAIN VIEW, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of g... Full story

Yahoo Finance • 6 months ago

Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

MOUNTAIN VIEW, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of g... Full story

Yahoo Finance • 6 months ago

Iridex Announces Strategic Investment in the Company

MOUNTAIN VIEW, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal... Full story

Yahoo Finance • 7 months ago

Iridex Comments on Recent Stock Price Volatility

MOUNTAIN VIEW, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal... Full story

Yahoo Finance • 7 months ago

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

MOUNTAIN VIEW, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal... Full story

Yahoo Finance • 2 years ago

Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation

MOUNTAIN VIEW, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of gl... Full story

Yahoo Finance • 2 years ago

Iridex Reports Third Quarter 2023 Financial Results and Business Update

MOUNTAIN VIEW, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of gl... Full story